Cardlytics, Inc. Revenue 2016–2025
Cardlytics, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cardlytics, Inc. revenue for the quarter ending March 31, 2026 was 34.3 M, a 39.19% decrease year-over-year.
- Cardlytics, Inc. revenue for the twelve months ending March 31, 2026 was 195.8 M, a 24.83% decrease year-over-year.
- Cardlytics, Inc. annual revenue for 2025 was 212.3 M, a 16.93% decrease from 2024.
- Cardlytics, Inc. annual revenue for 2024 was 255.6 M, a 10.44% decrease from 2023.
- Cardlytics, Inc. annual revenue for 2023 was 285.4 M, a 2.97% increase from 2022.
- Cardlytics, Inc. annual revenue for 2022 was 277.2 M.
Cardlytics, Inc. (CDLX) — Frequently Asked Questions
Cardlytics, Inc. (CDLX) is a publicly traded US company. It has a market capitalization of $253M. In fiscal 2025 it reported revenue of $212M and net income of -$103M. Explore CDLX's stock price, financial statements, earnings history, margins and key ratios below.
What is Cardlytics, Inc.'s market cap?
Cardlytics, Inc. (CDLX) has a market capitalization of $253M.
What is the CDLX stock price?
CDLX trades at $4.76 (-8.46% on the day).
How much revenue does Cardlytics, Inc. make?
Cardlytics, Inc. reported revenue of $212M in fiscal 2025.
Is CDLX profitable?
In fiscal 2025, Cardlytics, Inc. reported net income of -$103M.